Cumulative effect of intrinsic capacity domains on geriatric syndromes and functionality in older inpatients
View abstract on PubMed
Summary
This summary is machine-generated.Intrinsic capacity (IC) decline is common in older adults and predicts geriatric syndromes like frailty and falls. Assessing IC domains can help identify at-risk individuals for targeted interventions.
Area Of Science
- Gerontology
- Geriatric Medicine
- Public Health
Background
- Intrinsic capacity (IC) is a WHO-defined composite of physical and mental capacities, crucial for assessing functional reserve in older adults.
- IC encompasses five domains: locomotion, vitality, cognition, psychological well-being, and sensory function.
- Understanding the link between IC and geriatric syndromes is vital for effective healthcare strategies.
Purpose Of The Study
- To investigate the associations between intrinsic capacity domains and common geriatric syndromes in hospitalized older adults.
- To identify specific IC domains that predict geriatric syndromes.
- To inform the development of targeted interventions for at-risk older adults.
Main Methods
- A retrospective observational study included 245 hospitalized patients aged 60 years and older.
- Intrinsic capacity was assessed using gait speed, sensory function, cognitive tests (S-MMSE), quality of life (EuroQOL-5D), and nutritional status (Mini Nutritional Assessment).
- Geriatric syndromes including frailty, sarcopenia, falls, incontinence, and functional impairments (ADL/IADL) were evaluated using logistic regression models.
Main Results
- Nearly 60% of participants exhibited moderate to severe IC decline (score ≤ 2).
- Cognitive and vitality impairments were strongly associated with ADL/IADL disability (p < 0.001).
- Locomotor and vitality impairments predicted frailty and sarcopenia (p < 0.01), while cognitive impairment increased fall risk significantly (OR = 5.86).
Conclusions
- Intrinsic capacity impairments, especially in cognition, vitality, and locomotion, are prevalent in hospitalized older adults.
- These IC impairments are significant predictors of major geriatric syndromes.
- Routine IC assessment is recommended to identify individuals at risk and guide personalized interventions.
Related Concept Videos
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

